POSTPONED: The Congressional Agenda for “Comparative Effectiveness” in Health Care Reform: Strategies for Protecting Innovation in a Time of Rapid Change

, Bill Oldaker, Oldaker, Belair & Wittie, LLP/NHA; Joel Brill, MD, EBG Advisors/NHA
This event has been postponed. Harvard Club27 West 44th Street
New York, NY 10036

As the Obama Administration and the 111th Congress prepare to reform health care, join us for a  briefing and round table discussion of what might be done to ensure that comparative effectiveness is implemented in a manner that protects innovation.

Principals and staff from National Health Advisors (NHA) will offer insights into the framework for the debate, the Congressional agenda, potential positions and communication strategies in Congress and the federal regulatory agencies.

WHO SHOULD ATTEND?

Private Equity Sponsors of companies in the Medical Device, Biotechnology, and Pharmaceutical sectors, as well as representatives from their portfolio companies. 

Briefings will include perspectives from the following NHA personnel:

Comparative Effectiveness in Current Coverage,
Coding and Payment Policies Public and Private
Leslie Norwalk 
Former Acting Administrator - Centers for Medicare and Medicaid, EBG Advisors/NHA


Approaches on Congress' Agenda
Bill Oldaker 
Oldaker, Belair & Wittie, LLP/NHA

What Constitutes Evidence -- and How Can it be Measured?
Joel Brill, MD 
EBG Advisors/NHA
 
 
Paul Campbell 
EBG Advisors/NHA

There is no fee to attend this event.

Please RSVP no later than January 19, 2009.

 For more information or to register, click here.